4//SEC Filing
LaBrosse Nicole 4
Accession 0001415889-25-005299
CIK 0001159036other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:04 PM ET
Size
8.7 KB
Accession
0001415889-25-005299
Insider Transaction Report
Form 4
LaBrosse Nicole
SVP, CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Common Stock
2025-02-23+6,688→ 35,501 total - Exercise/Conversion
Restricted Stock Units
2025-02-23−6,688→ 20,063 totalExercise: $0.00→ Common Stock (6,688 underlying) - Tax Payment
Common Stock
2025-02-23$57.75/sh−3,601$207,958→ 31,900 total
Footnotes (2)
- [F1]The reported disposition of 3,601 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
- [F2]This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
Documents
Issuer
HALOZYME THERAPEUTICS, INC.
CIK 0001159036
Entity typeother
Related Parties
1- filerCIK 0001910662
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:04 PM ET
- Size
- 8.7 KB